Denise Rezende: Werfen Reflects on a Successful ISTH 2026 Congress
Denise Rezende, Product Manager of Systems Worldwide Marketing, Hemostasis at Werfen North America, shared a post on LinkedIn:
“Every congress tells a story, and ISTH 2026 was a remarkable one.
After months of planning, countless meetings, long days, and navigating the unexpected, it was incredibly rewarding to see everything come together in Paris.
One of the highlights for me was seeing our Presentation Theater completely full.
Reconnecting with colleagues, customers, and friends from around the world, exchanging ideas, and discussing the future of thrombosis and hemostasis reminded me why events like ISTH are so important.
They go far beyond showcasing innovation—they create opportunities to learn from one another, strengthen partnerships, and work together toward better patient care.
A sincere thank you to the International Society on Thrombosis and Hemostasis (ISTH) for organizing another outstanding congress, and to everyone who visited the Werfen booth, attended our presentations, and took the time to connect with our team.
Every conversation, every question, and every new connection made this experience even more meaningful.
A special thank you to my amazing colleagues.
Behind every successful event is a dedicated team committed to delivering excellence, supporting one another, and finding solutions every step of the way.
Your professionalism, collaboration, and commitment made all the difference, and I feel incredibly grateful to have shared this journey with all of you.
As I leave Paris, I take with me new ideas, stronger partnerships, inspiring conversations, and memories that will stay with me for a long time.
Until next time… see you at ISTH 2027 in Vancouver!”
Stay updated with Hemostasis Today.
-
Oct 19, 2026, 13:36Shobhna Ladva: Aspen Pharma EME Raises Awareness of Blood Clot Risks During Hormonal Transitions
-
Oct 19, 2026, 13:11Giulia Furnari: Connecting With Global Hematology Experts at IACH 2026
-
Oct 19, 2026, 12:46Andrew Choong: Recognizing Thrombosis Before It Becomes Life-Threatening
-
Oct 19, 2026, 11:37Beth Faiman: APSHO Fellows Celebrated for Advancing Hematology and Oncology Practice
-
Oct 19, 2026, 11:26Emanuele Pacini: Myelodysplastic Syndromes Research Featured at JSH Annual Meeting in Kyoto
-
Oct 19, 2026, 10:57Jesmond Dalli: How Erythroblasts Shape Neutrophil Development and Function
-
Oct 19, 2026, 10:41Hisham Fahmi: SCD – Should Gene Editing Begin Before Organ Damage?
-
Oct 19, 2026, 10:33Pallavi Madhiraju: YARTEMLEA Faces Another European Rejection Despite FDA Approval
-
Oct 19, 2026, 10:28Brig Tathagata Chatterjee: Acute Leukemias in AYAs at the Japanese Society of Hematology Conference